Related Experiment Video
Updated: Oct 1, 2025

Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma
Published on: November 4, 2010
Dexamethasone for Pediatric Critical Asthma: A Multicenter Descriptive Study
Austin R Sellers1, Meghan R Roddy2, Kristina K Darville3
1Institute for Clinical and Translational Research, 7582Johns Hopkins All Children's Hospital, St. Petersburg, FL, USA.
Dexamethasone prescribing is increasing for pediatric critical asthma, showing reduced severity and fewer adverse events compared to methylprednisolone. Further research is needed to determine optimal corticosteroid regimens.
Area of Science:
- Pediatric Critical Care Medicine
- Pharmacology
- Respiratory Medicine
Background:
- Systemic corticosteroids are crucial for managing severe pediatric asthma.
- Intravenous methylprednisolone is common, but dexamethasone is emerging as an alternative.
- This study examines corticosteroid prescribing trends in pediatric intensive care units.
Purpose of the Study:
- To assess trends and variations in corticosteroid prescribing for critical asthma in children.
- To compare outcomes associated with different corticosteroid regimens.
Main Methods:
- Multicenter retrospective cohort study using the Pediatric Health Information System (PHIS) registry.
- Included children aged 3-17 years admitted for critical asthma from 2011-2019.
- Analyzed corticosteroid prescribing rates, adverse events, interventions, mortality, and length of stay.
Main Results:
- Dexamethasone prescribing increased by 0.5% annually, with dexamethasone-alone use at 2.4%.
- Dexamethasone-alone was associated with reduced asthma severity, shorter hospital stays, and fewer adjunctive treatments.
- Adverse events like gastritis and hyperglycemia were less frequent with dexamethasone-alone.
Conclusions:
- Dexamethasone prescribing is rising for pediatric critical asthma.
- Variability in prescribing suggests a need for prospective studies to establish ideal corticosteroid regimens.
Related Concept Videos
Asthma-IV: Diagnostic and Management
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
COPD: Management Using Bronchodilators and Corticosteroids
Asthma-IV: Nursing Management
First, in...
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Asthma-III: Symptoms and Complications
Classification of Asthma

